ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
This Quarter Return
-3.66%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$244M
AUM Growth
+$244M
(-10%)
Cap. Flow
+$20M
Cap. Flow
% of AUM
8.2%
Top 10 Holdings %
Top 10 Hldgs %
92.96%
Holding
18
New
3
Increased
2
Reduced
10
Closed
1
Top Buys
| 1 |
Spero Therapeutics
SPRO
|
$28.5M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$6.55M |
| 3 |
Dianthus Therapeutics
DNTH
|
$6.52M |
| 4 |
AC Immune
ACIU
|
$2.26M |
| 5 |
Genmab
GMAB
|
$1.83M |
Top Sells
| 1 |
argenx
ARGX
|
$7.43M |
| 2 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$3.93M |
| 3 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$3.04M |
| 4 |
uniQure
QURE
|
$1.79M |
| 5 |
Arrowhead Research
ARWR
|
$1.72M |
Sector Composition
| 1 | Healthcare | 89.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Spero Therapeutics
SPRO
$116M
| $50.2M | 5.31% | 4,497,142 +2,554,061 | +131% | +$28.5M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $35.8M | 3.79% | 385,727 +70,698 | +22% | +$6.55M |
|
|
DRNA
3
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $24.7M | 2.62% | 1,374,776 -79,910 | -5% | -$1.44M |
|
|
4
uniQure
QURE
$896M
| $23.2M | 2.46% | 631,060 -48,560 | -7% | -$1.79M |
|
|
5
Arrowhead Research
ARWR
$3.05B
| $22.5M | 2.39% | 523,415 -39,876 | -7% | -$1.72M |
|
6
AnaptysBio
ANAB
$569M
| $21.8M | 2.31% | 1,477,652 -113,081 | -7% | -$1.67M |
|
|
NGM
7
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $16.2M | 1.72% | 1,018,334 -76,850 | -7% | -$1.22M |
|
8
Regenxbio
RGNX
$451M
| $14.1M | 1.49% | 510,760 -42,693 | -8% | -$1.17M |
|
9
ProQR Therapeutics
PRQR
$237M
| $10.9M | 1.16% | 2,281,966 -119,604 | -5% | -$573K |
|
|
PVLA
10
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $7.61M | 0.81% | 3,675,530 -1,900,000 | -34% | -$3.93M |
|
|
11
Dianthus Therapeutics
DNTH
$759M
| $6.52M | 0.69% | +958,618 | New | +$6.52M |
|
12
Galapagos
GLPG
$2.07B
| $4.62M | 0.49% | 32,534 -11,700 | -26% | -$1.66M |
|
|
13
AC Immune
ACIU
$205M
| $2.26M | 0.24% | +463,575 | New | +$2.26M |
|
|
14
argenx
ARGX
$43.6B
| $1.97M | 0.21% | 7,500 -28,300 | -79% | -$7.43M |
|
|
15
Genmab
GMAB
$15.3B
| $1.83M | 0.19% | +50,000 | New | +$1.83M |
|
16
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
17
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
|
MOR
18
DELISTED
MorphoSys AG American Depositary Shares
MOR
| – | – | -95,898 | Closed | -$3.04M |
|